首页> 外文期刊>Open Journal of Medicinal Chemistry >Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia
【24h】

Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia

机译:阿尔茨海默氏症和其他痴呆症的治疗和控制方面的最新进展

获取原文
       

摘要

Alzheimer’s disease (AD) is a neurodegenerative disease distinguished by progressive cognitive deterioration along with declining activities of daily living and behavioral changes. It is the commonest type of pre-senile and senile dementia. Many new therapeutic strategies have been developed in the last few years. We aimed at reviewing the evidence supporting these new therapeutic targets, including anti-amyloid and anti-Tau strategies. This review is focused on important future direction in investigation of potential therapeutic targets for AD drug discovery. Medical advances have improved treatment of many diseases but still there is a need to establish new tools for early diagnosis of AD. A thorough comprehensive understanding of the unexplored mechanism can ameliorate the diagnostic and therapeutic management of AD. There have been several disease-modifying therapeutic strategies for AD in the last few years and are presently at various phases of investigation. Few of them have shown promising results, but their safety and efficacy need to be further explored.
机译:阿尔茨海默氏病(AD)是一种神经退行性疾病,其特征在于进行性认知能力下降以及日常生活活动和行为变化的下降。它是老年前和老年性痴呆的最常见类型。在最近几年中已经开发了许多新的治疗策略。我们旨在审查支持这些新治疗靶标的证据,包括抗淀粉样蛋白和抗Tau策略。这篇综述的重点是研究AD药物发现的潜在治疗靶标的重要未来方向。医学上的进步改善了许多疾病的治疗,但是仍然需要建立新的工具来早期诊断AD。对尚未探索的机制的全面理解可以改善AD的诊断和治疗管理。在过去的几年中,已经有几种改善AD的疾病治疗策略,并且目前处于研究的各个阶段。他们中几乎没有显示出可喜的结果,但是它们的安全性和功效有待进一步探讨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号